Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoglobulin in RIC Allogeneic HSCT for Hematological and Kidney Cancers
NCT00787761Phase 2Completed
- Sponsor
- Northside Hospital
- Start
- Apr 2007
- Primary completion
- Jul 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label trial of antithymocyte globulin in Chronic Myeloid Leukemia (CML), chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma (NHL) and 7 more, sponsored by Northside Hospital. Started Apr 2007; status: completed.
02
Drugs
antithymocyte globulin
03
Conditions
Chronic Myeloid Leukemia (CML)chronic lymphocytic leukemia (CLL)non-Hodgkin lymphoma (NHL)multiple myeloma (MM)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00787761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00787761.